| Della Query, MD | |
|
12950 Highland Crossing Drive, Ste. H, Herndon, VA 20171 | |
| (703) 860-4200 | |
| (703) 860-1528 |
| Full Name | Della Query |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 12950 Highland Crossing Drive, Herndon, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619957271 | NPI | - | NPPES |
| 006723225 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101055921 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Della Query, MD 12950 Highland Crossing Drive, Ste. H, Herndon, VA 20171 Ph: (703) 860-4200 | Della Query, MD 12950 Highland Crossing Drive, Ste. H, Herndon, VA 20171 Ph: (703) 860-4200 |
News Archive
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Boehringer Ingelheim in connection with its Aggrenox Aspirin/Extended- Release Dipyridamole) 25 mg/200 mg capsules.
Emerging Healthcare Solutions, Inc. enthusiastically welcomed a highly anticipated report that Apple has unveiled the new iPhone 4.0 Operating System, which the Company believes will greatly benefit the MedAnywhere medical app currently in development. Specifically, new multitasking ability can be applied so that a physician can initiate patient monitoring subroutines without having to exit the MedAnywhere live communications portal.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a compound in soybeans is effective in reducing the frequency and severity of hot flashes in menopausal women.
S*BIO Pte Ltd today announced the initiation of a Phase 2 clinical trial of SB939, its novel orally-active HDAC inhibitor, in patients with recurrent or metastatic prostate cancer (HRPC).
Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.
› Verified 1 days ago
Subarna B Dharia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12950 Highland Crossing Drive, Ste. H, Herndon, VA 20171 Phone: 703-860-4200 Fax: 703-860-1528 | |
Mrs. Jennifer P Ferrer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12950 Highland Crossing Drive, Ste. H, Herndon, VA 20171 Phone: 703-860-4200 Fax: 703-860-1528 | |
Kalpana Thammineni, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 171 Elden Street, 200, Herndon, VA 20170 Phone: 305-984-6031 | |
Dr. Shadi Tabba, Pediatrics Medicare: Medicare Enrolled Practice Location: 171 Elden St, Suite 2c4, Herndon, VA 20170 Phone: 571-612-2606 | |
Deborah D Foley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12930 Worldgate Dr Ste 300, Herndon, VA 20170 Phone: 703-657-5500 | |
Mr. Salah M Neberai, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 110 Elden St, D, Herndon, VA 20170 Phone: 703-471-6996 Fax: 703-435-7762 | |
Mr. Amin Akhlaghi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12950 Highland Crossing Dr Ste H, Herndon, VA 20171 Phone: 703-860-4200 |